Future studies should explore therapeutic interventions such as antibiotics aimed at controlling retinal and brain Cp infection, attenuating NLRP3 inflammasome activity, or enhancing microglial phagocytosis to prevent or mitigate AD-related neurodegeneration. Here, NLRP3 is linked to Alzheimer disease.